We modified the liquid-chromatographic assay of Schleicher and Wieland (J Clin Chem Clin Biochem 1981 ;19:81-7) for measuring lysine-bound glucose in serum proteins, increasing its performance and practicality. After precipitating serum proteins from 10-to 50-pt samples with ethanol (700 mL/L) and hydrolyzing these in 6 mol/L HCI, we inject 20 tL of the diluted hydrolysate directly into the chromatograph, which consists of an acid-resistant C15 precolumn combined with a high-resolution C18 main column. The eluent is 3.5 mmol/L H3P04 solution containing 30 mL of acetonitrile per liter. These modifications increase sensitivity, provide excellent resolution and longevity of stationary phases, shorten assay times to 15 to 20 mm, and are suited for automation. The assay is highly sensitive and highly specific, quantifying nanomoles of lysine-bound glucose per milligram of protein.
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A precision (CV) of 5.1% is achievable at physiological and supra-physiological glucose concentrations, and analytical recovery is 99%. This inexpensive method has been applied to serum albumin, bulk serum proteins, and preparations of The extent of glycation is proportional to both the glucose concentration in the protein's environment and the duration of the exposure to glucose. Thus, if the inherent biological half-life of a protein remains unaltered, glycation of this protein depends solely on the integrated glucose concentration over its lifespan.
An assay intended for use in the measurement of glycation should be both highly specific and highly sensitive. thus increasing the assay sensitivity.4
Human proteins exhibit a large number of lysine residues, each of which can bind glucose at the a-NH2 group. In contrast, most assays of glycated hemoglobin measure only the glycated N-terminal valine of the /3-chain, so that only a single amino acidglucose adduct per protein molecule can be detected.
The degree of glycation of serum proteins provides an index of glycemia over about the preceding two weeks, compared with about six weeks for glycated hemoglobin. Because shorter changes and smaller swings of glycemia can be detected (4), clinical sensitivity is increased. Given their location in the serum compartment, the glycation of serum proteins better reflects glycemia, whereas glycated hemoglobin reflects the intra-erythrocytic glucose concentrations.
Despite these very promising features, Schleicher and Wieland's method has encountered some practical problems; it is time-consuming (40-60 mm per run), and is not very reproducible on high-resolution stationary phases. Even different lots of the original column material did not reproduce the chromatographic resolution (E. Schleicher, personal communication, 1985) .
Here we describe three modifications of this assay, to enhance its performance and practicality.
The yield of furosine is increased (by modified precipitation conditions); resolution is improved, and also column longevity, through use of a modified stationary phase; and modifying the mobile phase has shortened assay time.
Materials and Methods
Protein isolation and hydrolysis procedures. We isolated the bulk of the proteins from human serum and from heparin-, EDTA-, or citrate-treated plasma by precipitation with either uranyl acetate (at room temperature), trichloroacetic acid (at 4 #{176}C), or various proportions of ethanol and water (at 4#{176}C). The protein precipitate from 50 pt of plasma or serum was then hydrolyzed in 500 L of 6 molJL HC1. Hydrolysis conditions were as in reference 3. We diluted these hydrolysates fivefold with distilled water and injected 20 pt of this diluted sample onto the chromatographic column.
In addition to serum proteins, we isolated human immunoglobulins of the IgG subclass by passing serum through a column containing Protein A-Sepharose CL 4B (Pharmacia Diagnostics, Uppsala, Sweden) (5), precipitating and hydrolyzing these isolated IgG as with serum proteins.
For a third class of proteins, we isolated low-density lipoproteins (LDL) from human plasma by rate zonal ultraBriefly, this method is based on purifying the protein (a simple precipitation step when plasma proteins are being assayed), followed by hydrolysis of the precipitate in 6 mol/L HCI. Under these conditions, 30% of the lysine-glucose adducts are transformed to furosine, and proteins are hydrolyzed to their individual component amino acids. In an isocratic reversed-phase HPLC assay, both furosine and tyrosine are quantified at 280 nm, which allows the number of the lysine-bound glucose molecules per molecule of protein to be determined. Filter, pore size 0.2 tm), then degassed it. Acetonitrile was added after degassmg. Using a flow rate of 0.8 mL/min, we tested several eluents in a large series of experiments. H3P04 was investigated over a concentration range of 1 to 15 mmol/L, as was pH over a range of 3 to 8 (adjusted by addition of KOH), and acetonitrile at different concentrations. All separations were performed at room temperature.
Other procedures. n-[5,6-3H}Glucose (New England Nuclear, Boston, MA; specific activity 78 kCi/mol) was incorporated into human serum albumin, as described elsewhere for t-
The furosine peak was identified and calibrated by an absolute standard containing a-amino-fructose-lysine (LysGlu), kindly provided by Dr. E. Schleicher, Munich, F.R.G. The homogeneity of this peak was monitored by measuring the ratio of the absorbances at 280 and 254 nm and by pretreatment of proteins with NaBH4 (Figure 1) , which hydrates the ketoamine linkage, thereby prohibiting furosine formation, as previously described in detail (3).
Results and Discussion
Of the three precipitation reagents tested-trichloroacetic acid, uranyl acetate, and ethanol-trichloroacetic acid was not useful because the precipitate was hardly soluble in HC1. We chose ethanol (700 mJJL) because it produced a greater yield of furosine than did uranyl acetate (Figure 2) . and 80 poorly-controlled diabetic subjects) precipitated in parallel with uranyl acetate, which was used as standard procedure in 4, and with 700 mL/L ethanol reagent, the mean increase of the furosine yield with ethanol precipitation was 39%. Dialysis of the protein solution before precipitation with ethanol did not decrease the yield of furosine (Figure 3) . Thus neither in solution nor in the aldimine form-which is removed by dialysis-could glucose be responsible for the increased furosine yield after ethanol precipitation.
Rather, it seems likely that more LysGlu binding sites are available for furosine formation after precipitation by ethanol. Fig. 1 . Chromatograpt,of a hydrolysateof (A) untreatedhuman serum albumin and ( after pretreatmentwith NaBH4,as described in ref.
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Furthermore, when compared with use of uranyl acetate, precipitation with ethanol yields cleaner precipitates and hydrolysates, so that about 500 runs can be made before replacing the precolumn, compared with only about 200 runs when uranyl acetate precipitates are assayed. However, both reagents precipitate the same components from serum. When the protein used for Lys-Glu standardization is precipitated with ethanol and a standard curve is constructed from its hydrolysate, the reference values obtained with the uranyl acetate precipitation remain fully valid. Therefore, normal and well-controlled diabetic ranges with this method are the same as found with the original method (4).
When hydrolysates from the bulk human serum proteins are subjected to HPLC, numerous peaks elute, most of which are not relevant to the assay. However, peaks for furosine and tyrosine must be fully resolved from all the other peaks, which requires use of a high-resolution column. (Tyrosine is used for internal standardization of the hydrolyzed protein mass.) On the other hand, to keep analysis time short, column length should be limited. Figure 4 shows the excellent separation achieved in hydrolysates from both pure human albumin ( Figure 4B ) and the bulk human plasma proteins ( Figure 4A ) with the 25-cm-long octadecylsilanepacked column. When we attempted to use the same material in the precolumn, it was useless after about 50 injections of the hydrolysate, resulting in unacceptably high costs. We therefore sought an acid-resistant material for the precolumn and found Nucleosil C18appropriate. With this combi- A major objective of this work was to maintain isocratic conditions, as were provided by the original method (3). With the above stationary phases, we found a 3.5 mmol/L H3P04 eluent most appropriate. It can be readily prepared, is inexpensive, and allows excellent chromatographic resolution. With minor changes in molarity, retention time of the furosine peak can readily be shifted without significantly affecting the retention times of other peaks; e.g., increasing the eluent's molarity shortens the retention time for furosine. Such minor adjustments in molarity are necessary to resolve the furosine from the many peaks that appear in the chromatogram of hydrolysates of LDL ( Figure 5 ) and, to a lesser degree, from the hydrolysates of IgG (Figure 6 ). To keep assay time short, we include acetomtrile in the mobile phase at a concentration of 40 mL/L when a new analytical column is being used, decreasing this to about 10 mLIL after 2500 assays. This shortens running time to 15 mm with a new column and to about 20 mm after 2500 runs. The isocratic conditions give a very stable running time, making automation feasible: about 70 samples can be processed in 24 h with automated HPLC apparatus.
The intra-assay CV was 5.1% (n = 73, diabetic subjects) after precipitation of serum samples with ethanol and 4.8% (n = 66, diabetic subjects) after precipitation with uranyl acetate. The mean interassay CV of HPLC was 3.7% (n = 107 diabetic subjects). Analytical recovery of 15 pg of furosine added to hydrolysates of 30 plasma precipitates was 99.5% (SD 2.33%). The detection limit for furosine was about 0.3 pg in a 20-zL injection volume.
With the modifications presented here, we can increase the furosine yield, improve column resolution and longevity, and decrease running time to allow for automation. This procedure makes practicable a highly sensitive, specific, and 
